Stock News

Globus Med Inca (GMED) Valuation Rose While Us Bancorp De Lowered Its Holding by $403,850; As Hanesbrands (HBI) Market Valuation Declined, Lapides Asset Management Boosted Position

Globus Medical, Inc. (NYSE:GMED) Logo

Lapides Asset Management Llc increased its stake in Hanesbrands Inc (HBI) by 19.48% based on its latest 2017Q4 regulatory filing with the SEC. Lapides Asset Management Llc bought 30,800 shares as the company’s stock declined 7.94% with the market. The institutional investor held 188,900 shares of the clothing and shoe and accessory stores company at the end of 2017Q4, valued at $3.95M, up from 158,100 at the end of the previous reported quarter. Lapides Asset Management Llc who had been investing in Hanesbrands Inc for a number of months, seems to be bullish on the $6.57B market cap company. The stock increased 0.63% or $0.115 during the last trading session, reaching $18.235. About 2.77 million shares traded. Hanesbrands Inc. (NYSE:HBI) has declined 8.16% since May 22, 2017 and is downtrending. It has underperformed by 19.71% the S&P500.

Us Bancorp De decreased its stake in Globus Med Inca (GMED) by 25.28% based on its latest 2017Q4 regulatory filing with the SEC. Us Bancorp De sold 9,850 shares as the company’s stock rose 22.30% while stock markets declined. The institutional investor held 29,121 shares of the health care company at the end of 2017Q4, valued at $1.20M, down from 38,971 at the end of the previous reported quarter. Us Bancorp De who had been investing in Globus Med Inca for a number of months, seems to be less bullish one the $5.12B market cap company. The stock increased 0.61% or $0.32 during the last trading session, reaching $52.65. About 185,083 shares traded. Globus Medical, Inc. (NYSE:GMED) has risen 65.36% since May 22, 2017 and is uptrending. It has outperformed by 53.81% the S&P500.

More important recent Hanesbrands Inc. (NYSE:HBI) news were published by: Seekingalpha.com which released: “Hanesbrands: Honing In On A Swing Low” on May 15, 2018, also Seekingalpha.com published article titled: “Hanesbrands: A Defensive Cash Cow”, Seekingalpha.com published: “HanesBrands: Value-Investor Opportunity” on April 25, 2018. More interesting news about Hanesbrands Inc. (NYSE:HBI) was released by: Seekingalpha.com and their article: “Small Cap Dividend Spotlight: HanesBrands” with publication date: April 29, 2018.

Investors sentiment decreased to 1.11 in 2017 Q4. Its down 0.04, from 1.15 in 2017Q3. It is negative, as 75 investors sold HBI shares while 173 reduced holdings. 79 funds opened positions while 197 raised stakes. 337.77 million shares or 0.93% more from 334.65 million shares in 2017Q3 were reported. Commonwealth Bank Of Aus has invested 0% in Hanesbrands Inc. (NYSE:HBI). Goelzer Invest Management reported 264,856 shares or 0.62% of all its holdings. P Schoenfeld Asset Limited Partnership holds 37,927 shares or 0.06% of its portfolio. Shufro Rose And Communication Limited Co has invested 0.66% of its portfolio in Hanesbrands Inc. (NYSE:HBI). The Colorado-based Cetera Advsrs Ltd Llc has invested 0.05% in Hanesbrands Inc. (NYSE:HBI). Penobscot Inv Mngmt Company holds 52,505 shares or 0.3% of its portfolio. Freestone Ltd Liability Corporation stated it has 0.29% of its portfolio in Hanesbrands Inc. (NYSE:HBI). Petrus Tru Lta holds 18,046 shares. Wealthtrust Axiom Ltd Liability Corporation has invested 1.18% in Hanesbrands Inc. (NYSE:HBI). Tocqueville Asset Mgmt Limited Partnership has invested 0.06% in Hanesbrands Inc. (NYSE:HBI). Willingdon Wealth Mngmt invested in 0.37% or 53,555 shares. Check Mgmt Inc Ca reported 2.50M shares. Beck Mgmt Ltd Liability Com holds 37,857 shares or 0.35% of its portfolio. Cannell Peter B & Company holds 0.18% of its portfolio in Hanesbrands Inc. (NYSE:HBI) for 251,139 shares. Burt Wealth Advsr invested in 0.02% or 1,400 shares.

Among 21 analysts covering Hanesbrands (NYSE:HBI), 11 have Buy rating, 0 Sell and 10 Hold. Therefore 52% are positive. Hanesbrands had 64 analyst reports since September 17, 2015 according to SRatingsIntel. The rating was maintained by Barclays Capital with “Overweight” on Thursday, January 25. The stock of Hanesbrands Inc. (NYSE:HBI) earned “Hold” rating by Stifel Nicolaus on Monday, September 25. On Friday, February 9 the stock rating was maintained by Wells Fargo with “Market Perform”. The stock has “Hold” rating by Bank of America on Friday, April 6. The rating was maintained by Stifel Nicolaus on Thursday, February 8 with “Hold”. Cowen & Co maintained it with “Hold” rating and $22.0 target in Thursday, August 24 report. The company was downgraded on Thursday, September 21 by Nomura. The firm earned “Buy” rating on Tuesday, August 29 by Oppenheimer. Goldman Sachs upgraded the stock to “Conviction Buy” rating in Friday, December 4 report. Morgan Stanley maintained Hanesbrands Inc. (NYSE:HBI) rating on Thursday, November 2. Morgan Stanley has “Equal-Weight” rating and $23 target.

Since February 15, 2018, it had 0 insider purchases, and 1 insider sale for $1.07 million activity.

Lapides Asset Management Llc, which manages about $912.08 million and $460.98 million US Long portfolio, decreased its stake in American Vanguard Corp (NYSE:AVD) by 18,000 shares to 343,100 shares, valued at $6.74M in 2017Q4, according to the filing. It also reduced its holding in Cree Inc (NASDAQ:CREE) by 96,700 shares in the quarter, leaving it with 43,400 shares, and cut its stake in Web.Com Group Inc (NASDAQ:WWWW).

Investors sentiment decreased to 0.99 in Q4 2017. Its down 0.39, from 1.38 in 2017Q3. It turned negative, as 26 investors sold GMED shares while 83 reduced holdings. 40 funds opened positions while 68 raised stakes. 59.89 million shares or 7.54% less from 64.77 million shares in 2017Q3 were reported. Mutual Of America Capital Lc holds 58,892 shares. State Common Retirement Fund stated it has 0% of its portfolio in Globus Medical, Inc. (NYSE:GMED). Balyasny Asset Mngmt Ltd Liability Corporation reported 0.01% of its portfolio in Globus Medical, Inc. (NYSE:GMED). Barclays Plc reported 0% in Globus Medical, Inc. (NYSE:GMED). Voya Invest Lc stated it has 0.01% of its portfolio in Globus Medical, Inc. (NYSE:GMED). Contravisory Investment Mngmt Inc invested 0% in Globus Medical, Inc. (NYSE:GMED). Strs Ohio accumulated 0.01% or 35,700 shares. Reilly Limited Com reported 472 shares. Fny Managed Accounts Limited Liability Com holds 81 shares. Peak6 Invs L P, a Illinois-based fund reported 102,817 shares. Sei Invs accumulated 43,984 shares or 0.01% of the stock. Meritage Portfolio Mngmt reported 158,750 shares. Smithfield Trust owns 90 shares or 0% of their US portfolio. Nordea Mgmt Ab has invested 0.01% in Globus Medical, Inc. (NYSE:GMED). Dimensional Fund Advsr LP holds 0.03% in Globus Medical, Inc. (NYSE:GMED) or 1.75 million shares.

Us Bancorp De, which manages about $32.70B US Long portfolio, upped its stake in First Republic Bank San Fran (NYSE:FRC) by 24,934 shares to 53,357 shares, valued at $4.62 million in 2017Q4, according to the filing. It also increased its holding in Delta Air Lines Inc (NYSE:DAL) by 62,492 shares in the quarter, for a total of 1.58 million shares, and has risen its stake in Newfield Expl Co (NYSE:NFX).

Among 15 analysts covering Globus Medical Inc (NYSE:GMED), 9 have Buy rating, 2 Sell and 4 Hold. Therefore 60% are positive. Globus Medical Inc had 51 analyst reports since August 3, 2015 according to SRatingsIntel. Morgan Stanley maintained the stock with “Overweight” rating in Thursday, May 3 report. The rating was maintained by Morgan Stanley with “Overweight” on Thursday, February 22. The rating was initiated by Needham on Tuesday, September 26 with “Hold”. The firm earned “Buy” rating on Thursday, February 22 by Piper Jaffray. The firm has “Buy” rating given on Tuesday, September 19 by Canaccord Genuity. The rating was maintained by Oppenheimer with “Hold” on Thursday, August 3. Piper Jaffray maintained Globus Medical, Inc. (NYSE:GMED) on Tuesday, July 18 with “Buy” rating. Leerink Swann maintained the shares of GMED in report on Wednesday, March 28 with “Buy” rating. As per Wednesday, November 9, the company rating was downgraded by Oppenheimer. UBS initiated Globus Medical, Inc. (NYSE:GMED) on Tuesday, September 22 with “Buy” rating.

More important recent Globus Medical, Inc. (NYSE:GMED) news were published by: Seekingalpha.com which released: “Globus Medical: Innovating Beyond The Spine Market” on April 30, 2018, also Globenewswire.com published article titled: “Globus Medical Reports First Quarter 2018 Results”, Seekingalpha.com published: “Globus Medical (GMED) Q1 2018 Results – Earnings Call Transcript” on May 03, 2018. More interesting news about Globus Medical, Inc. (NYSE:GMED) was released by: Globenewswire.com and their article: “Globus Medical Announces Positive Clinical Results for Lateral Expandable Technology” with publication date: May 15, 2018.

Hanesbrands Inc. (NYSE:HBI) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *